Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.
暂无分享,去创建一个
H. Aburatani | A. Lenis | H. Kume | Y. Homma | S. Miyano | J. Coleman | Y. Shiraishi | K. Chiba | Hiromichi Suzuki | S. Ogawa | D. Solit | Y. Shiozawa | M. Fukayama | Yusuke Sato | T. Yoshizato | S. Maekawa | G. Nagae | Kenichi Yoshida | T. Morikawa | M. Sanada | T. Ushiku | Taka-Aki Sato | Y. Fujii | H. Makishima | Y. Nannya | T. Nakagawa | A. Yokoyama | Kosuke Aoki | K. Kataoka | N. Kakiuchi | T. Kawai | Hiroko Tanaka | E. Sugihara | Y. Ochi | M. Nakagawa | Jimpei Miyakawa | Y. Takeuchi | Y. Inoue | Hiromichi Suzuki | Teppei Morikawa
[1] Tao Xu,et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium , 2020, Science.
[2] Andrew Menzies,et al. Extensive heterogeneity in somatic mutation and selection in the human bladder , 2020, Science.
[3] Hu Zhao,et al. The prognostic value of tumor architecture in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy , 2020, Medicine.
[4] S. Ishikawa,et al. Defined lifestyle and germline factors predispose Asian populations to gastric cancer , 2020, Science Advances.
[5] Giovanni Parmigiani,et al. ComBat-seq: batch effect adjustment for RNA-seq count data , 2020, bioRxiv.
[6] Zhuo Song,et al. Detection of bladder cancer using urinary cell-free DNA and cellular DNA , 2020, Clinical and Translational Medicine.
[7] H. Ikeuchi,et al. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis , 2019, Nature.
[8] O. Traxer,et al. Complications of ureteroscopy: a complete overview , 2019, World Journal of Urology.
[9] J. Desai,et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity , 2019, Nature.
[10] M. Rubin,et al. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling , 2019, Nature Communications.
[11] M. Zeegers,et al. Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification , 2019, BJU international.
[12] G. Netto,et al. Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma , 2019, Cancer science.
[13] S. Tsunoda,et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers , 2019, Nature.
[14] Ville Mustonen,et al. The repertoire of mutational signatures in human cancer , 2018, Nature.
[15] Mauro A. A. Castro,et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer , 2019, European urology.
[16] B. Taylor,et al. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma , 2018, Clinical Cancer Research.
[17] Edwin Cuppen,et al. MutationalPatterns: comprehensive genome-wide analysis of mutational processes , 2016, Genome Medicine.
[18] Ludmila V. Danilova,et al. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy , 2018, eLife.
[19] M. Höglund,et al. Molecular subtype classification of urothelial carcinoma in Lynch syndrome , 2018, Molecular oncology.
[20] B. Taylor,et al. Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome , 2018, JCO precision oncology.
[21] R. Bourgon,et al. TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.
[22] M. Babjuk,et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. , 2015, European urology.
[23] Jian Yang,et al. Chromothripsis Detection and Characterization Using the CTLPScanner Web Server. , 2018, Methods in molecular biology.
[24] N. Schultz,et al. NEXT GENERATION SEQUENCING OF NON‐MUSCLE INVASIVE BLADDER CANCER REVEALS POTENTIAL BIOMARKERS AND RATIONAL THERAPEUTIC TARGETS: PD48‐11 , 2017, European urology.
[25] Chuang Tan,et al. Universal Patterns of Selection in Cancer and Somatic Tissues , 2018, Cell.
[26] Olivia Alder,et al. Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. , 2017, Cancer cell.
[27] Steven J. M. Jones,et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer , 2017, Cell.
[28] D. Wheeler,et al. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma. , 2017, European urology.
[29] David L. Marron,et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations , 2017, Nature Communications.
[30] S. Miyano,et al. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. , 2017, Blood.
[31] Birgit Sikkema-Raddatz,et al. GAVIN: Gene-Aware Variant INterpretation for medical sequencing , 2017, Genome Biology.
[32] Junhao Lei,et al. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi‐institutional analysis of 795 cases , 2016, BJU international.
[33] K. Bensalah,et al. Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract. , 2016, Urology.
[34] M. L. Calle,et al. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma. , 2016, Cancer cell.
[35] Nicola D. Roberts,et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.
[36] Jaroslav Bendl,et al. PredictSNP2: A Unified Platform for Accurately Evaluating SNP Effects by Exploiting the Different Characteristics of Variants in Distinct Genomic Regions , 2016, PLoS Comput. Biol..
[37] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[38] N. Schultz,et al. Genomic Characterization of Upper Tract Urothelial Carcinoma. , 2015, European urology.
[39] H. Aburatani,et al. Integrated molecular analysis of adult T cell leukemia/lymphoma , 2015, Nature Genetics.
[40] Hiromi Nakamura,et al. Genomic spectra of biliary tract cancer , 2015, Nature Genetics.
[41] M. Stephens,et al. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures , 2015, bioRxiv.
[42] Satoru Miyano,et al. Mutational landscape and clonal architecture in grade II and III gliomas , 2015, Nature Genetics.
[43] N. Hacohen,et al. Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.
[44] Colin Campbell,et al. An integrative approach to predicting the functional effects of non-coding and coding sequence variation , 2015, Bioinform..
[45] Eli Upfal,et al. Accurate Computation of Survival Statistics in Genome-Wide Studies , 2013, PLoS Comput. Biol..
[46] Benjamin J. Raphael,et al. Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.
[47] K. Baggerly,et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. , 2014, Cancer cell.
[48] Steven J. M. Jones,et al. Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.
[49] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[50] M. Jinzaki,et al. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study. , 2014, Urologic oncology.
[51] Huanming Yang,et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation , 2013, Nature Genetics.
[52] G. Getz,et al. Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.
[53] German Tischler,et al. biobambam: tools for read pair collation based algorithms on BAM files , 2013, Source Code for Biology and Medicine.
[54] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[55] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[56] H. Kume,et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data , 2013, Nucleic acids research.
[57] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..
[58] Mårten Fernö,et al. A Molecular Taxonomy for Urothelial Carcinoma , 2012, Clinical Cancer Research.
[59] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[60] Arthur P. Grollman,et al. Aristolochic acid-associated urothelial cancer in Taiwan , 2012, Proceedings of the National Academy of Sciences.
[61] Aedín C. Culhane,et al. survcomp: an R/Bioconductor package for performance assessment and comparison of survival models , 2011, Bioinform..
[62] S. Sugano,et al. Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.
[63] Yair Lotan,et al. Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma , 2011, BJU international.
[64] Huanming Yang,et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder , 2011, Nature Genetics.
[65] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[66] J. Raman,et al. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005 , 2011, BJU international.
[67] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[68] Matthew D. Wilkerson,et al. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..
[69] James Bailey,et al. Information Theoretic Measures for Clusterings Comparison: Variants, Properties, Normalization and Correction for Chance , 2010, J. Mach. Learn. Res..
[70] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[71] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[72] Motohiro Kato,et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. , 2007, American journal of human genetics.
[73] Shigeru Chiba,et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.
[74] W. J. Kent,et al. BLAT--the BLAST-like alignment tool. , 2002, Genome research.
[75] G. Papanicolaou. Cytology of the urine sediment in neoplasms of the urinary tract. , 1947, The Journal of urology.